We collaborate with 50 clinical research sites to evaluate the efficacy of new investigational treatments according to ICH GCP guidelines.
This research study is evaluating an investigational treatment to see if it can help improve bone density in postmenopausal women with osteoporosis. Patients will be asked to participate in this research study for approximately 18 months.
To participate in this study patients must: Be female, be 50 years or older at the time of the study and be postmenopausal. Other eligibility criteria apply. Study participants receive the investigational treatment at no cost and compensation for time and travel may be available. This advert was approved by SAHPRA and UFS HSREC.
Join a clinical research study and help us improve patient access to wet age-related macular degeneration (AMD) treatments!
The study is testing an investigational medication that is a proposed ‘biosimilar’ to Eylea®, a AMD treatment, that is already approved for use.
Take part in this study if you:
* are 50 years or older
* were diagnosed with wet AMD
* had no previous treatment for wet AMD
Study duration: +_ 56 weeks with 11 visits. You will receive all study medication and any test needed to be done as per the study protocol.
This study is approved by SAHPRA and an ethics committee.